Skip to main content

COVID19

  • COVID-19

COVAX

  • COVAX

Country Hub

  • Country portal | COVAX platform

Secondary nav

  • Global Vaccine Impact Conference
  • Ethics Hotline

Donate

  • Donate
  • EN
  • FR
Home

Main navigation

Menu
  • Our Alliance
    Our Alliance
    • About
    • Strategy
      • Vaccine Investment Strategy 2024
      • Phase 5 (2021-2025)
        • The equity goal
        • The healthy markets goal
        • The sustainability goal
        • The vaccine goal
      • Phase 4 (2016-2020)
        • The market shaping goal
        • The sustainability goal
        • The systems goal
        • The vaccine goal
      • Phase 3 (2011-2015)
        • The financing goal
        • The health systems goal
        • The market shaping goal
        • The vaccine goal
      • Phase 2 (2006-2010)
      • Phase 1 (2000-2005)
      • Risk management
      • Learning System Strategy
      • Vaccine Investment Strategy 2018
      • Gender and immunisation
    • Operating model
      • Gavi's partnership model
        • The Bill & Melinda Gates Foundation
        • UNICEF
        • WHO
        • The World Bank Group
        • Civil Society: Driving Increased Equity in Immunisation
        • Developing country governments
        • Developing country pharmaceutical industry
        • Industrialised country governments
        • Industralised country pharmaceutical industry
        • Research and technical institutes
      • Gavi's business model
      • Gavi Secretariat
      • Transparency and IATI
    • Governance
      • Gavi Board
        • Board Committees
        • Board composition
        • Board members
        • Board and Committee minutes
        • Calendar
      • Governance and legal structures
      • Corporate Policies
      • Audit and Investigations
    • Market Shaping
      • The Vaccine Innovation Prioritisation Strategy
      • Market Shaping roadmaps
      • Product information for vaccines and cold chain equipment
      • Vaccine demand forecasting
    • Global Health & Development
      • Decade of vaccine collaboration
      • International Health Partnership for UHC 2030
      • Millennium Development Goals
      • Sustainable Development Goals
      • UN Global Strategy for Women's, Children's and Adolescents' Health
    • Work with us
      • Culture
      • Vacancies
      • Internship programme
      • RFPs and Consulting Opportunities

    @SaveTheChildren / Hanna Adcock

    #VaccinesWork
     

    Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

    FOCUS AREAS Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board


    CAREERS Current vacancies Internship programme RFPs and consulting


    Contact us Phishing and fraud

  • Programmes & Impact
    Programmes & Impact
    • How our support works
      • Gavi Support Guidelines
      • Independent Review Committee
      • Joint appraisals
      • Country portal and COVAX collaboration platform
    • Types of support
      • Vaccine support
        • Human papillomavirus
        • Inactivated polio vaccine
        • Japanese encephalitis
        • Measles and measles-rubella
        • Meningitis A
        • Oral cholera
        • Pentavalent
        • Pneumococcal
        • Rotavirus
        • Typhoid
        • Yellow fever
      • Health system and immunisation strengthening
        • Immunisation supply chain
        • Data
        • Leadership, management and coordination
        • Learning and Performance Management (LPM)
        • Demand promotion
      • Partners' engagement framework
        • Targeted country assistance
        • Strategic focus areas
        • Foundational support
      • Making immunisation sustainable
        • Eligibility
        • Gavi’s approach to engaging with middle-income countries
        • Co-financing
      • Civil society organisation
    • Country Hub
      • Africa
        • Angola
        • Benin
        • Burkina Faso
        • Burundi
        • Cameroon
        • Central African Republic (the)
        • Chad
        • Comoros
        • Congo
        • Congo, DR
        • Côte d’Ivoire
        • Eritrea
        • Ethiopia
        • Gambia
        • Ghana
        • Guinea
        • Guinea-Bissau
        • Kenya
        • Lesotho
        • Liberia
        • Madagascar
        • Malawi
        • Mali
        • Mauritania
        • Mozambique
        • Niger
        • Nigeria
        • Rwanda
        • Sao Tome and Principe
        • Senegal
        • Sierra Leone
        • South Sudan
        • Tanzania, UR
        • Togo
        • Uganda
        • Zambia
        • Zimbabwe
      • Americas
        • Bolivia
        • Cuba
        • Guyana
        • Haiti
        • Honduras
        • Nicaragua
      • Eastern Mediterranean
        • Afghanistan
        • Djibouti
        • Pakistan
        • Somalia
        • Sudan
        • Yemen
      • Europe
        • Albania
        • Armenia
        • Azerbaijan
        • Bosnia & Herzegovina
        • Georgia
        • Kyrgyzstan
        • Moldova
        • Tajikistan
        • Turkmenistan
        • Ukraine
        • Uzbekistan
      • Southeast Asia
        • Bangladesh
        • Bhutan
        • India
        • Indonesia
        • Korea, DPR
        • Myanmar
        • Nepal
        • Sri Lanka
        • Timor Leste
      • Western Pacific
        • Cambodia
        • China
        • Kiribati
        • Lao PDR
        • Mongolia
        • Papua New Guinea
        • Solomon islands
        • Vietnam
    • Our impact
      • Measuring our performance
        • 2011–2015 indicators
        • 2016–2020 indicators
        • 2021–2025 indicators
      • Countries approved for support
      • Disbursements and Commitments
      • Evaluation studies
      • Facts and figures
      • Progress reports
    • Programmatic policies
      • Co-financing policy
      • Fragility, emergencies and displaced populations policy
      • Gender policy
      • Health system and immunisation strengthening policy
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency and accountability
      • Vaccine donation policy

    SUPPORTED COUNTRIESSupported countriesDetailed information on each Gavi-eligible country

    Explore our Country Hub

    FOR COUNTRIES

    Apply for support

    Gavi 5.0 Ceilings by country and support type

     

    OUR RESULTS

    Evaluation studies

    Facts and figures

    Progress reports

  • Investing in Gavi
    Investing in Gavi
    • Resource mobilisation process
      • Raising Generation immUnity: Global vaccine impact conference
      • The Gavi COVAX AMC 2022 Investment Opportunity
      • Gavi COVAX AMC Summit 2021
      • Gavi COVAX AMC Investment Opportunity 2021 Launch Event
      • Global Vaccine Summit 2020
      • Gavi's Investment Opportunity launch meeting, 30 August 2019
      • Gavi Mid-Term Review, Abu Dhabi high level conference, 10-11 December 2018
      • Previous events
        • Gavi pledging conference January 2015
        • Gavi replenishment launch meeting May 2014
        • Gavi Mid-Term Review meeting October 2013
        • Gavi pledging conference June 2011
        • Call for Action and Resources October 2010
        • Financing Country Demand March 2010
    • Funding
      • Overview 2000-2037
      • Current period 2021-2025
      • Donor profiles
        • AerCap Ireland Limited
        • Airtel Nigeria
        • Al Ansari Exchange
        • Alight Solutions
        • Alwaleed Philanthropies
        • Analog Devices Foundation
        • Arm Limited
        • Asia Philanthropy Circle (APC)
        • Audacious Alliance
        • Australia
        • Austria
        • Bahrain
        • Belgium
        • Bhutan
        • The Bill & Melinda Gates Foundation
        • Blackberry
        • Brazil
        • Burkina Faso
        • Cameroon
        • Canada
        • Centene Charitable Foundation
        • China
        • Cisco
        • Coca-Cola Foundation
        • CODE (RED) Campaign
        • Collins Aerospace (Goodrich Corporation)
        • Colombia
        • Croatia
        • Denmark
        • Dolby Laboratories Charitable Fund
        • ELMA Vaccines and Immunization Foundation
        • Epiroc AB
        • Estonia
        • Etsy
        • European Commission
        • Finland
        • France
        • Germany
        • Girl Effect
        • Google
        • Greece
        • HH Sheikh Mohammed bin Zayed Al Nahyan
        • Iceland
        • India
        • International Federation of Pharmaceutical Wholesalers
        • Ireland
        • Italy
        • Japan
        • Gamers without Borders
        • Kuwait
        • "la Caixa" Banking Foundation
        • Laerdal
        • Liechtenstein
        • Luxembourg
        • Malaysia
        • Malta
        • Mastercard
        • Mauritius
        • McHugh O'Donovan Foundation
        • Mexico
        • Monaco
        • Netherlands
        • New Zealand
        • Niger
        • Norway
        • Oman
        • Orange
        • Other private donors
        • Pager Duty
        • Philippines
        • Poland
        • Portugal
        • Pratt & Whitney
        • Proctor & Gamble
        • Qatar
        • Reed Hastings and Patty Quillin
        • Republic of Korea
        • Republic of Moldova
        • Rockefeller Foundation
        • Russell Reynolds Associates
        • Russian Federation
        • Salesforce
        • Saudi Arabia
        • Shell International
        • Singapore
        • Slovenia
        • SMBC Aviation Capital Limited
        • South Africa
        • Spain
        • Spotify
        • Stanley Black & Decker
        • Sweden
        • Switzerland
        • SymAsia Foundation
        • Thistledown Foundation
        • TikTok
        • Toyota Tsusho
        • Twilio
        • Uganda
        • UBS Optimus Foundation
        • Unilever
        • United Kingdom
        • United States of America
        • UPS
        • Vaccine Forward Initiative
        • Viet Nam
        • The Visa Foundation
        • WHO Foundation-Go Give One Campaign
        • Wise
        • Workday Foundation
    • Partnering with business
    • Innovative financing
      • IFFIm
      • Pneumococcal AMC
        • About the pneumococcal AMC
        • How it works
        • Manufacturers
        • How countries can apply
        • Timeline
        • Independent Assessment Committee
        • AMC legal agreements
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    The Global Vaccine Impact Conference explained

    KEY AREAS

    Donor profiles

    Matching Fund

    Pneumococcal AMC

  • VaccinesWork
    VaccinesWork
    • About VaccinesWork
    • The science behind COVID-19
    • Emerging threats
    • Tales from the past
    • News from the lab
    • Stories from the community

    FEATURED STORY

    A mother and small child photographed during a vaccine campaign in Bangladesh. Credit: Ashraful Arefin

    Eight things you need to know about the state of global immunisation


    Read more

  • News & Resources
    News & Resources
    • Media room
      • News releases
      • Media contacts
      • Leadership biographies
    • Publications
    • Document library
      • COVAX data brief
      • COVID-19 situation reports
      • Evaluations
      • IRC reports
      • Financial reports
    • Knowledge Products

    KEY PUBLICATION

    Download the 2021 Gavi progress report


    The 2023 Mid-Term Review Report

    PROGRESS REPORT

    Download the 2021 Gavi progress report

  • The Break COVID Now Summit

  • EN
  • FR
  • Home
  • VaccinesWork
  • How Ethiopia is maintaining health services during a pandemic?
WHO/Ethiopia/Otto Bakano
Back to

How Ethiopia is maintaining health services during a pandemic?

Ethiopia has overtaken Nigeria to become the Gavi-eligible African country most affected by COVID-19. Over the past week, the number of confirmed cases in Ethiopia has grown exponentially. Despite the pandemic, immunisation activities – both routine and campaign – are ongoing in Ethiopia.

14 September 2020

8 September situation report
Back to

How Ethiopia is maintaining health services during a pandemic?

Ethiopia has overtaken Nigeria to become the Gavi-eligible African country most affected by COVID-19. Over the past week, the number of confirmed cases in Ethiopia has grown exponentially. Despite the pandemic, immunisation activities – both routine and campaign – are ongoing in Ethiopia.

14 September 2020

8 September situation report
COVID-19COVAX
  • by Gavi Staff
  • Home

    Footer

    • Our Alliance
    • Programmes & impact
    • Investing in Gavi
    • VaccinesWork
    • News & resources

    Country Hub

    • Country portal | COVAX platform

    Donate

    • Donate

    Footer nav

    • Careers
    • Contact
    • Ethics hotline
    • IFFIm
    • Privacy Policy
    • Terms of use
    • Phishing and fraud

    © Gavi 2023

    • Gavi LinkedIn
    • Gavi Twitter
    • Gavi Instagram
    • Gavi Facebook
    • Gavi YouTube
    • Gavi TikTok

    Our achievements are thanks to the support and expertise of our founding partners